EUVIMEDEUVIMED entdecken
Crossref

Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism

Jiaxin Ren, Cheng Zhao, Ruizhu Sun, Jian Sun, Laiya Lu, Jun Wu, Shuaijun Li, Lei Cui iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Jiaxin Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reconstructive and Regenerative Surgery, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the lack of a precise in vitro model that can mimic the nature microenvironment in osteosarcoma, the understanding of its resistance to chemical drugs remains limited. Here, we report a novel three‐dimensional model of osteosarcoma constructed by seeding tumor cells (MG‐63 and MNNG/HOS Cl no. 5) within demineralized bone matrix scaffolds. Demineralized bone matrix scaffolds retain the original components of the natural bone matrix (hydroxyapatite and collagen type I), and possess good biocompatibility allowing osteosarcoma cells to proliferate and aggregate into clusters within the pores. Growing within the scaffold conferred elevated resistance to doxorubicin on MG‐63 and MNNG/HOS Cl no. 5 cell lines as compared to two‐dimensional cultures. Transcriptomic analysis showed an increased enrichment for drug resistance genes along with enhanced glutamine metabolism in osteosarcoma cells in demineralized bone matrix scaffolds. Inhibition of glutamine metabolism resulted in a decrease in drug resistance of osteosarcoma, which could be restored by α‐ketoglutarate supplementation. Overall, our study suggests that microenvironmental cues in demineralized bone matrix scaffolds can enhance osteosarcoma drug responses and that targeting glutamine metabolism may be a strategy for treating osteosarcoma drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaHumansGlutamineBone MatrixMethylnitronitrosoguanidineCell Line, TumorDrug ResistanceTumor Microenvironment

Stichwörter der Autor:innen

decalcified bone matrixdrug resistanceglutamine metabolismosteosarcoma

Substanzen

GlutamineMethylnitronitrosoguanidine

Autor:innen und Institutionen

  • Department of Reconstructive and Regenerative Surgery, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Stem Cells and Regenerative Medicine, Tongji University School of Medicine, Shanghai, China.
  • CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.

ORCID-Profile: Lei Cui

Zitieren

APA

Ren, J., Zhao, C., Sun, R., Sun, J., Lu, L., Wu, J., Li, S., & Cui, L. (2024). Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism. International Journal of Cancer. https://doi.org/10.1002/ijc.34841

Vancouver

Ren J, Zhao C, Sun R, Sun J, Lu L, Wu J, et al. Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism. International Journal of Cancer. 2024. doi:10.1002/ijc.34841

BibTeX
@article{Ren2024,
  author = {Ren, Jiaxin and Zhao, Cheng and Sun, Ruizhu and Sun, Jian and Lu, Laiya and Wu, Jun and Li, Shuaijun and Cui, Lei},
  title = {Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34841}
}
Kostenlos starten →